Category: Long COVID
Long COVID symptoms can improve, but their resolution is slow and imperfect
The Conversation Around 5–10% of people who get infected with SARS-CoV-2 will experience symptoms that persist way beyond the initial acute period, a clinical syndrome we are learning more about, known widely as long COVID. Shortness of breath, brain fog, lethargy and tiredness, loss of smell or taste are common features of long COVID, as is the development […]
Sep 5, 2023
‘Elegant’ study connects COVID with mitochondria gene disruptions, paving way for new treatments
Fierce Biotech Scientists and clinicians studying COVID-19 have long suspected that the disease doesn’t just affect the lungs, but many other organ systems too. Now, researchers have identified a mechanism that could explain why and reveal new pathways to find treatments for long COVID. In a study published Aug. 9 in Science, a team led by Children’s Hospital of […]
Aug 15, 2023
Long COVID: Mitochondria, the Big Miss, and Hope
Medscape This week there was news on Long COVID in two very different directions: emergence of strong data to support mitochondrial dysfunction as the basis for the condition in some people, and learning how the $1.15 billion allocation to the NIH RECOVER initiative has largely been wasted. In this edition of Ground Truths, I’ll review […]
Aug 15, 2023
A new clue to the reason some people come down with long COVID
NPR Stéphanie Longet is an immunologist and a COVID researcher at the University of Saint-Etienne in France, and just like 10-20% of adults who were infected with the virus, she continues to have symptoms well after her infection has resolved – a condition known colloquially as long COVID. “I got COVID one year ago and I […]
Aug 8, 2023
NIH launches trials for long-COVID treatments: what scientists think
Nature World’s largest study of long COVID will evaluate potential therapies for brain fog, sleep disruption and more. The US National Institutes of Health (NIH) announced yesterday that it will launch its first trials to test the safety and efficacy of treatments against long COVID. These trials will focus on therapies aimed at some of […]
Aug 1, 2023
Challenges in Developing Long COVID Criteria
MedPageToday In a recent JAMA article, researchers provided a new approach for identifying individuals with post-acute sequelae of SARS-CoV-2 (PASC), commonly referred to as long COVID. Because this article — from Tanayott Thaweethai, PhD, and colleagues — was part of the large, federally funded U.S. RECOVER study of long COVID, it will be influential among scientists around […]
Aug 1, 2023
Long COVID Persists as a Mass Disabling Event
MedPageToday The latest CDC data on long COVID in U.S. adults and an alarming World Health Organization (WHO) statement about its long-term impact underscore the pandemic’s lingering and debilitating effects. Like the satirical film “Don’t Look Up,” in which scientists couldn’t focus media or politicians on the climate crisis, most Americans are content to avert their eyes […]
Jul 25, 2023
Researchers discover unique blood plasma protein patterns in patients with long COVID
Medical Express Using advanced research techniques, including a form of artificial intelligence, a team of researchers has discovered unique patterns of blood plasma proteins in patients with suspected long COVID that could improve patient outcomes. This research, which used multiple state-of the-art technologies, was enabled by existing expertise and infrastructure through CHRI. It was published […]
Jul 5, 2023
Long COVID not caused by COVID-19 immune inflammatory response, new research finds
EurekaAlert Long Covid, which affects nearly two-million people in the UK1, is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds. Emerging data demonstrates that immune activation may persist for months after COVID-19. In this new study, published in eLife today [4 July], researchers wanted to find out whether persistent immune activation and […]
Jul 5, 2023
Transmission Briefs
What exactly is “long COVID” (aka “post-acute sequelae SARS-CoV-2,” or PASC)? How do you know if you have it? Dr. Lawler answers commonly asked questions in this first of a three-part Transmission Briefs series on long COVID/PASC.
Jun 27, 2023